XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues $ 6,316 $ 7,652
Cost of revenues 6,630 7,518
Gross (loss)/profit (314) 134
Operating expenses    
Sales and marketing expenses 48 69
General and administrative expenses 932 1,548
Research and development expenses 18 68
Total operating expenses 998 1,685
Loss from operations (1,312) (1,551)
Other income/(expenses)    
Interest income 72 46
Other expenses, net (5) (9)
Change in fair value of warrant liabilities 101 795
Total other income 168 832
Income tax benefit 1 2
Net income (loss) (1,143) (717)
Net loss (1,143) (717)
Foreign currency translation loss (81) (22)
Comprehensive loss $ (1,224) $ (739)
Loss per common share    
Basic and diluted** (in dollars per share) [1] $ (0.16) $ (0.10)
Weighted average number of common shares outstanding:    
Basic and diluted** (in shares) [1] 7,174,506 7,079,962
Unrelated Parties [Member]    
Other income/(expenses)    
Loss before income tax benefit $ (1,144) $ (719)
Related Parties [Member]    
Other income/(expenses)    
Net income (loss) (1,143) (717)
Net loss $ (1,143) $ (717)
[1] Retrospectively restated for effect of the 1-for-5 reverse stock split effective on January 18, 2023, see Note 4(g).